http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4522814-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d93ff11d3a2f1fe0da2d17393255ca9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-12
filingDate 1982-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfd8f9792b61658755a33eccad3bd6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb84e3bd3cb0aaeac8de1204fbb8bae
publicationDate 1985-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4522814-A
titleOfInvention Composition of matter from Cryptosiphonia woodii useful for the treatment of herpes simplex virus
abstract A water extract of homogenized Cryptosiphonia woodii is useful for the treatment of herpes simplex viral infections. The active agent in the extract is a polysaccharide containing glucose and galactose. Herpes infections may be treated in subjects, e.g. human patients, by administering to the subject an effective amount of an aqueous extract of C. woodii, particularly a water extract. This treatment method is effective for treating subjects both prior to and subsequent to infection. It may involve topical application to alleviate symptoms associated with herpes infections or desirably may be systemic, e.g. by oral administration, to eradicate the virus and thereby prevent symptom recurrence.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5100879-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4883830-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4783446-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5585365-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4696816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4840941-A
priorityDate 1982-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4229440-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129744730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226453303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226453304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129739415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22734939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128691975

Total number of triples: 42.